Daniel Nadler

The AI Product Going Viral With Doctors: OpenEvidence, with CEO Daniel Nadler

Daniel Nadler, Pat Grady

Open Evidence currently scales to over 400,000 global monthly active physicians through a direct-to-pro model that bypasses traditional enterprise sales by relying on word-of-mouth adoption. The platform distinguishes itself by training exclusively on peer-reviewed literature, including a strategic partnership with the New England Journal of Medicine, to prevent hallucinations while enabling doctors to resolve complex comorbidities that standard search engines cannot address. Co-founder Daniel Nadler projects this technology could prevent 300,000 to 800,000 deaths annually within five years, with a long-term vision of achieving hyper-personalized medicine to extend human life expectancy toward 120 to 130 years.